July 6, 2017
San Francisco-based Mendel.ai, a startup that is developing an artificial intelligence-powered platform to match people with cancer to clinical trials, has raised $2 million in seed funding from DCM Ventures, BootstrapLabs, Indie Bio, LaunchCapital and SOSV. Medel.ai will use the capital to forge partnerships with hospitals and cancer genomics companies to bring the system into use.
April 25, 2016
Augmedix, a San Francisco-based startup that uses Google Glass to reduce the time physicians spend on documentation, has raised $17 million in strategic investments in a round that includes some of its largest health plan customers: Sutter Health, Dignity Health, Catholic Health Initiatives (CHI), TriHealth Inc. and one other which chose to remain anonymous. Some traditional VCs also participated...
January 12, 2015
San Francisco-based Augmedix, which has developed a Google Glass clinical documentation offering for physicians raised $16 million in a round co-led by existing investors Emergence Capital and DCM Ventures. Augmedix has received $23 million in venture funding to date, according to the company.
Other existing investors include Great Oaks Venture Capital, and Rock Health’s LPs (Kleiner Perkins,...